All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”
OC08003

Structure, recognition, and processing of DNA damage by metal-based compounds of biological significance

Public support

  • Provider

    Ministry of Education, Youth and Sports

  • Programme

    COST

  • Call for proposals

    COST 6 (SMSM2008OC3)

  • Main participants

  • Contest type

    VS - Public tender

  • Contract ID

    1146/2010-32

Alternative language

  • Project name in Czech

    Struktura, rozlišení a zpracování poškození DNA protinádorově účinnými sloučeninami kovů

  • Annotation in Czech

    Budou získány poznatky o strukturních a biochemických vlastnostech DNA modifikované protinádorově účinnými komplexy platiny a ruthenia. Tyto poznatky budou využity ke zpřesnění vztahů mezi strukturou a farmakologickou aktivitou metalofarmak.

Scientific branches

  • R&D category

    ZV - Basic research

  • CEP classification - main branch

    BO - Biophysics

  • CEP - secondary branch

    CE - Biochemistry

  • CEP - another secondary branch

    FR - Pharmacology and apothecary chemistry

  • OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    10608 - Biochemistry and molecular biology<br>10609 - Biochemical research methods<br>10610 - Biophysics<br>30104 - Pharmacology and pharmacy

Completed project evaluation

  • Provider evaluation

    V - Vynikající výsledky projektu (s mezinárodním významem atd.)

  • Project results evaluation

    Molecular mechanisms underlying antitumor effects of new transition metal-based complexes, namely platinum and ruthenium complexes have been described. These complexes belong to the new generation of promising anticancer metallodrugs which exhibit antitumor effects in tumor cells resistant to conventional cisplatin and its analogues in clinical use.

Solution timeline

  • Realization period - beginning

    Jan 1, 2008

  • Realization period - end

    Jul 31, 2011

  • Project status

    U - Finished project

  • Latest support payment

    Feb 22, 2011

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP12-MSM-OC-U/01:1

  • Data delivery date

    Jul 12, 2012

Finance

  • Total approved costs

    1,791 thou. CZK

  • Public financial support

    1,791 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    0 thou. CZK